Investor Type | Firm |
Industries | IT (& TMT) • Hardware (& Manufacturing) • HealthTech (& Fitness) • Advertising |
Stages | Early,Seed |
Investing | Spain |
Investment Range | $240,000 - $240,000 |
Finaves is a venture capital firm associated with IESE Business School, established in 2000. They specialize in seed, start-up, early venture, and mezzanine investments. The firm is focused on a diverse set of industries, including environment, information technology, services, and retail sectors. Also, as one of the most experienced venture capital investors in Spain, Finaves leverages its extensive network to assist entrepreneurs in realizing their business visions and in developing into conscious leaders with a definite purpose. They collaborate with individuals who have a responsible strategy and are dedicated to long-term projects, emphasizing the belief that personal development is a precursor to company building. Finaves is an integral component of the IESE entrepreneurial ecosystem, which nurtures new ventures, innovation, and growth. Their values encompass commitment, modesty, growth, and community, promoting a balance between offering comprehensive support and respecting the autonomy of the entrepreneurs. Finaves' investment thesis is geared towards Seed and Pre-Series A stages, with investment tickets ranging from €100,000 to €500,000, primarily targeting Spain. They are sector-agnostic and prefer co-investment with other venture capitalists. The value proposition of Finaves includes exclusive access to IESE's talent pool, strategic advisory services without interfering with daily operations, transparent sharing of knowledge, and an extensive network developed over 25 years of experience. Their impressive track record includes the creation of more than 58 companies, generating over 1,200 jobs, and an investment sum of €16 million. Finaves is recognized for its practicality, entrepreneurial spirit, and its vast network that has been significant to its portfolio companies, including notable names like Cooltra and Advance Medical.